| The importance of social capital to the management of multinational enterprises: Relational networks among Asian and Western firms MA Hitt, HU Lee, E Yucel Asia pacific journal of Management 19, 353-372, 2002 | 640 | 2002 |
| Advances in global leadership WH Mobley, Y Wang, M Li Emerald Group Publishing Limited, 2012 | 117 | 2012 |
| The symptom burden of treatment‐naive patients with head and neck cancer EY Hanna, TR Mendoza, DI Rosenthal, GB Gunn, P Sehra, E Yucel, ... Cancer 121 (5), 766-773, 2015 | 71 | 2015 |
| Strategic leadership in global business organizations: Building trust and social capital MA Hitt, BW Keats, E Yucel Advances in global leadership 3, 9-35, 2003 | 70 | 2003 |
| Adverse drug reactions due to drug–drug interactions with proton pump inhibitors: assessment of systematic reviews with AMSTAR method E Yucel, M Sancar, A Yucel, B Okuyan Expert opinion on drug safety 15 (2), 223-236, 2016 | 33 | 2016 |
| Estimation of minimally important differences and responder definitions for EORTC QLQ‐MY20 scores in multiple myeloma patients K Sully, A Trigg, N Bonner, A Moreno‐Koehler, C Trennery, N Shah, ... European journal of haematology 103 (5), 500-509, 2019 | 31 | 2019 |
| Measuring therapy-induced peripheral neuropathy: preliminary development and validation of the treatment-induced neuropathy assessment scale TR Mendoza, XS Wang, LA Williams, Q Shi, EG Vichaya, PM Dougherty, ... The Journal of Pain 16 (10), 1032-1043, 2015 | 31 | 2015 |
| Convenience, satisfaction, health-related quality of life of once-weekly 70 mg/m2 vs. twice-weekly 27 mg/m2 carfilzomib (randomized A.R.R.O.W. study) P Moreau, S Kumar, R Boccia, S Iida, H Goldschmidt, K Cocks, A Trigg, ... Leukemia 33 (12), 2934-2946, 2019 | 27 | 2019 |
| Validation of the Turkish version of medication regimen complexity index among elderly patients B Okuyan, B Babi, M Sancar, P Ay, E Yücel, A Yücel, FV Izzettin Journal of evaluation in clinical practice 22 (5), 732-736, 2016 | 26 | 2016 |
| Burden of disease progression in patients with multiple myeloma in the US M Hagiwara, S Panjabi, T Delea, E Yucel, R Fonseca Leukemia & lymphoma 61 (1), 47-55, 2020 | 23 | 2020 |
| Health-related and economic burden among family caregivers of patients with acute myeloid leukemia or hematological malignancies E Yucel, S Zhang, S Panjabi Advances in Therapy, 1-23, 2021 | 18 | 2021 |
| The use of proxies and proxy-reported measures: a report of the international society for quality of life research (ISOQOL) proxy task force JK Roydhouse, ML Cohen, HR Eshoj, N Corsini, E Yucel, C Rutherford, ... Quality of Life Research, 1-11, 2021 | 13 | 2021 |
| Adaptation and evaluation of a symptom-monitoring digital health intervention for patients with relapsed and refractory multiple myeloma: pilot mixed-methods implementation study N Biran, RA Kouyaté, E Yucel, GE McGovern, AM Schoenthaler, ... JMIR formative research 4 (11), e18982, 2020 | 9 | 2020 |
| Association between low-testosterone and kidney stones in US men: the national health and nutrition examination survey 2011–2012 E Yucel, S DeSantis, MA Smith, DS Lopez Preventive medicine reports 10, 248, 2018 | 6 | 2018 |
| Measuring symptoms as a critical component of drug development and evaluation in hematological diseases LA Williams, E Yucel, JE Cortes, CS Cleeland Clinical investigation 3 (12), 1127, 2013 | 5 | 2013 |
| Development and content validation of the Satisfaction and Experience Questionnaire for Granulocyte Colony-Stimulating factor (SEQ-G-CSF) A Yucel, A Skalicky, OR Eseyin, E Yucel, R Belani, M Bensink Journal of Patient-Reported Outcomes 5 (1), 1-13, 2021 | 4 | 2021 |
| Economic burden of disease progression among multiple myeloma patients who have received transplant and at least one line of therapy in the US R Fonseca, M Hagiwara, S Panjabi, E Yucel, J Buchanan, T Delea Blood cancer journal 11 (2), 35, 2021 | 3 | 2021 |
| Burden of disease progression in patients with multiple myeloma who have received at least one line of therapy in the US M Hagiwara, T Delea, S Panjabi, E Yucel, R Fonseca Blood 132, 4754, 2018 | 3 | 2018 |
| Incidence of acute kidney injury (AKI) and its impact on patient outcomes among adult hospitalized patients with carbapenem-resistant Gram-negative infections who received … TP Lodise, E Yucel, EN Obi, AH Watanabe, BH Nathanson Journal of Antimicrobial Chemotherapy 79 (1), 82-95, 2024 | 2 | 2024 |
| Economic burden of disease progression among transplant eligible multiple myeloma patients who have received at least one line of therapy in the US R Fonseca, M Hagiwara, S Panjabi, E Yucel, J Buchanan, T Delea Blood 134, 2211, 2019 | 2 | 2019 |
Michael A. HittProfessor of Management, Texas A&M UniversityVerified email at mays.tamu.edu
